I-Beta Blockers Isetyenziselwa Ukunyanga Iimeko ezininzi Zonyango
Iibet blockers ziphakathi kwezilwanyana ezisetyenziswa kakhulu kumayeza. Basebenza ngokuthintela umphumo we-adrenaline kwizicubu, ngokukodwa, ngokuthintela "i-beta receptors" ebopha i-adrenaline. Phakathi kwezinye izinto, le ndlela yokukhusela ibheji yokunciphisa izinga lentliziyo, ukunciphisa amandla okuqhaqhalwa kweentliziyo zomzimba, ukunciphisa inani le-oksijini intliziyo yesidingo kufuneka yenze umsebenzi wayo, ukunciphisa uxinzelelo kwi-system ye-vascular, kwaye ithambe ukunciphisa igazi uxinzelelo.
Ngenxa yokuba le miphumo, akumangalisi ukuba i-beta blockers ibonakalise iluncedo ekuphatheni imeko ezininzi zezonyango, ingakumbi iingxaki ze-cardiovascular problems. Ezi ziquka:
- angina
- xi nzelelo
- ukukhubazeka kwentliziyo
- i-arrhythmias ye-cardiac, ngakumbi i-fibrillation ye-agriyo
- i-myocardial infarction (intliziyo yesifo )
- i-aortic dissection
- i-hypertrophic cardiomyopathy
- migraine intloko
- ukukhathazeka kwentlalo
Ababethi beta beyona ndlela yokuqala yonyango kwizigulane ezine-angina ezizinzile, i-myocardial infarction, kunye nokuhluleka kwentliziyo. Ngokuqhelekileyo ayisebenzisi njengonyango lokuqala loxinzelelo lwexinzelelo, kodwa lunokuba luncedo xa kukho unyango lweziyobisi olufunekayo ukulawula uxinzelelo lwegazi.
- Funda malunga ne-beta blockers ye-angina.
- Funda malunga nokunyanga kwenhliziyo.
- Funda ngo kunyango lwegazi.
Ngokuqhelekileyo asetyenziswe iBeta Blockers
Ngenxa yokusetyenziswa ezininzi kwe-beta blockers, mhlawumbi akumangalisi ukuba iinkampani zonyango ziye zavelisa ezimbalwa zazo.
Nalu uluhlu lwabasebenzisi be-beta blockers (igama eliqhelekileyo - igama lezorhwebo):
- I-Acebutolol - iSectral
- Atenolol - Tenormin
- Betaxolol - Kerlone
- Bisoprolol - uZebeta, uthengiswa njengoZiac
- Cardolol - Cartrol
- Carvedilol - Coreg
- I-Labetalol - Normodyne, ibuye ithengiswe njengeTrandate
- I-Metoprolol - Lopressor, ibuye ithengiswe njengeTostrol
- Nadolol - Corgard
- Penbutolol - Levatol
- Propranolol - Inderal, Inderal LA
- Timolol - Blocadren
Indlela i-Beta Blockers ithathwa ngayo
Kukho ngokucacileyo ezininzi ezahlukeneyo ze-beta blockers ezikhoyo, kwaye imiyalelo ethile malunga nokuba kaninzi kangakanani na ixesha lomhla wokuyithatha iyahlukahluka kwiziyobisi ukuya kwiziyobisi. Nangona kunjalo, njengomgaqo-jikelele umphumo weziphumo zecala ye-beta blockers inokuncitshiswa ngokubamba ngesidlo-oku kubangela ukuba ezi ziyobisi zifakwe kancane kancane.
Imiphumo emibi yeBeta Blockers
Iimiphumo zecala ze-beta blockers zixhomekeke ngokukodwa kwindlela yazo yokusebenza, oko kukuthi, kwiziphumo zabo zokuvimbela i-adrenaline. Imiphumo ibandakanya:
- Ukuphuculwa kweempawu kubantu abane- asthma . Oku mhlawumbi umphumo wecala lomgca we-beta blockers.
- Ukuphuculwa kweempawu kubantu abane- arterial disease .
- Ukwenza u-hypoglycemia (isishukela ephantsi kwegazi) ngakumbi kubantu abanesifo sikashukela .
- Ukuxinezeleka
- Ukukhathala
- Izandla ezibandayo
- Intloko
- Ukutyunjwa
- Ukungasebenzi kwezesondo
Abasetyhini abakhulelweyo beta blockers bayagwenywa xa kunokwenzeka, kuba banokuchaphazela umntwana ngokubangela ukunyuka kwenhliziyo, ukunciphisa uxinzelelo lwegazi kunye neqondo eliphantsi lokushukela kwegazi.
Ngokuqhelekileyo iziphumo ezichaphazelekayo ze-beta blockers zihlala zilawulwa ngokukhetha ngokukhethekileyo apho i-beta blocker ekhethiweyo, kunye nokuzama ukusebenzisa amanani amancinci.
Imithombo:
Fihn SD, Gardin JM, Abrams J, et al. Isikhokelo se-ACCF / AHA / ACP / AATS / PCNA / SCAI / STS yokuxilongwa kunye nokulawulwa kwezigulane ezinezifo zesifo senhliziyo esisisigxina: ingxelo ye-American College of Cardiology Foundation / i-American Heart Association iqela elikukhokelo, kunye ne-American Ikholeji yamaGqirha, i-American Association ye-Thoracic Surgery, i-Preventive Cardiovascular Association Association, uMbutho we-Cardiovascular Angiography kunye neNongenelelo, kunye noMbutho weeNgcali zeTriracic. Ukuhamba ngo-2012; 126: e354.
UKUBHALA IKOMITI YAMALUNGU, Yancy CW, Jessup M, et al. I-ACCF / I-AHA isikhokelo sokulawula ukuhluleka kwentliziyo: ingxelo ye-American College of Cardiology Foundation / i-American Heart Association Task Force kwizikhokelo zokusebenza. Uhambo luka-2013; 128: e240.